tributyrin has been researched along with Cancer of Colon in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Oliveira, TF; Furtado, KS; Heidor, R; Miranda, ML; Moreno, FS; Ortega, JF; Purgatto, E; Tavares, PE; Vieira, A | 1 |
Le Maux, S; Li, Y; McClements, DJ; Xiao, H | 1 |
Hong, SS; Kang, SN; Lee, MK; Lim, SJ | 1 |
Clarke, KO; Feinman, R; Harrison, LE | 1 |
Maurer, HR; Schröder, CP | 1 |
Deschner, EE; Lupton, JR; Newmark, HL; Ruperto, JF | 1 |
6 other study(ies) available for tributyrin and Cancer of Colon
Article | Year |
---|---|
The chemopreventive activity of the histone deacetylase inhibitor tributyrin in colon carcinogenesis involves the induction of apoptosis and reduction of DNA damage.
Topics: 1,2-Dimethylhydrazine; Animals; Anticarcinogenic Agents; Apoptosis; Colonic Neoplasms; Deoxyguanosine; DNA Damage; Histone Deacetylase Inhibitors; Male; Precancerous Conditions; Rats; Rats, Wistar; Triglycerides; Weight Gain | 2014 |
Emulsion-based delivery systems for tributyrin, a potential colon cancer preventative agent.
Topics: Anticarcinogenic Agents; Colonic Neoplasms; Corn Oil; Drug Delivery Systems; Drug Stability; Emulsions; HT29 Cells; Humans; Solubility; Triglycerides | 2009 |
Dual function of tributyrin emulsion: solubilization and enhancement of anticancer effect of celecoxib.
Topics: Animals; Antineoplastic Agents; Celecoxib; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Drug Carriers; Drug Synergism; Emulsions; HCT116 Cells; Humans; Melanoma; Mice; Oils; Particle Size; Prodrugs; Pyrazoles; Solubility; Sulfonamides; Surface-Active Agents; Triglycerides | 2012 |
Tributyrin, an oral butyrate analogue, induces apoptosis through the activation of caspase-3.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Butyrates; Caspase 3; Caspases; CDC2-CDC28 Kinases; Cell Cycle Proteins; Colonic Neoplasms; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; DNA-Binding Proteins; E2F Transcription Factors; E2F4 Transcription Factor; Enzyme Activation; G1 Phase; Neoplasm Proteins; Nuclear Proteins; Phenotype; Phenylbutyrates; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Retinoblastoma Protein; Transcription Factors; Triglycerides; Tumor Cells, Cultured | 2001 |
Tributyrin-induced differentiation promotes apoptosis of LS 174T colon cancer cells in vitro.
Topics: Adenocarcinoma; Alkaline Phosphatase; Apoptosis; Caspase Inhibitors; Caspases; Cell Cycle; Cell Differentiation; Cell Division; Colonic Neoplasms; Enzyme Inhibitors; Humans; Triglycerides; Tumor Cells, Cultured | 2002 |
Dietary butyrate (tributyrin) does not enhance AOM-induced colon tumorigenesis.
Topics: Animals; Azo Compounds; Azoxymethane; Body Weight; Cocarcinogenesis; Colonic Neoplasms; Diet; Drug Evaluation, Preclinical; Fatty Acids; Feces; Female; Mice; Precancerous Conditions; Triglycerides | 1990 |